TGA reforms
11 July 2012
The TGA mandate is to regulate medicines, medical devices and biological products throughout their lifecycle. The TGA is focusing on implementing changes to ensure a greater emphasis on transparency of regulatory decision-making processes, a continuing focus on business process reform and a more strategic approach to the use of information technology to support regulatory operations. These changes will ensure a smooth transition to the Australia New Zealand Therapeutic Products Agency.
Reforms underway as part of TGA Reforms: a blueprint for TGA's future include:
- Advertising of therapeutic goods
- Complementary medicines regulatory reforms
- Medical devices reforms
- Medicine labelling and packaging review
- Over-the-counter business process reforms
- Streamlined Submission Process project (prescription medicines)
Content last updated: Wednesday, 11 July 2012
Content last reviewed: Wednesday, 11 July 2012
Web page last updated: Wednesday, 11 July 2012
URL: http://www.tga.gov.au/about/tga-reforms.htm